Myeloma Trial Supports 'Personalized Approach' to Upfront Transplant

(MedPage Today) -- CHICAGO--The progression-free survival (PFS) benefit with autologous stem-cell transplantation (ASCT) in newly diagnosed multiple myeloma was confirmed in the DETERMINATION study, yet the lack of overall survival difference...